ReNeuron Group PLC | Ownership
Companies that own ReNeuron Group PLC
Woodford Investment Management Ltd.
11,238,212
35.51%
40,891
0.09%
07/31/2018
Invesco Asset Management Ltd.
3,770,118
11.91%
3,770,118
0.01%
07/13/2018
Hargreaves Lansdown Stockbrokers Ltd.
1,435,000
4.54%
169,000
0.01%
08/01/2018
Hargreaves Lansdown Asset Management Ltd.
986,000
3.12%
168,000
0.01%
08/01/2018
Smith & Williamson Investment Management LLP
493,000
1.56%
29,000
0.01%
08/01/2018
Jarvis Investment Management Ltd.
384,000
1.21%
65,000
0.04%
08/01/2018
Walker Crips Stockbrokers Ltd.
367,000
1.15%
134,000
0.02%
08/01/2018
Aviva Investors Global Services Ltd.
359,438
1.13%
359,438
0%
07/13/2018
HSBC Global Asset Management (UK) Ltd.
319,000
1.01%
41,000
0%
08/01/2018
Hargreave Hale Ltd.
280,000
0.89%
0
0%
08/01/2018
| Address |
Pencoed Business Park
Pencoed BJ CF35 5HY
United Kingdom
|
|
Employees
|
- |
| Website |
http://reneuron.com |
| Updated |
07/08/2019 |
| ReNeuron Group Plc engages in the development of novel cell based therapies that target significant areas of unmet medical need. It develops its core stem cell assets such as CTX neural cell line and human retinal progenitor cells. The company was founded by John David Sinden in 1997 and is headquartered in Pencoed, the United Kingdom. |
